CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration

Journal of Bone and Mineral Research

Volumn 21, Issue 1, 2006, Pages 48-57

  Ishida, Norihiro ^a   Hayashi, Koji ^b   Hattori, Asuka ^a   Yogo, Keiichiro ^a   Kimura, Toru ^b   Takeya, Tatsuo ^a,c  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c NONE   (Japan)

Author keywords

Bone marrow cells; CCR1; Cell migration; NFAT2; RAW264 cells

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR1; CYCLOSPORIN A; GLUTATHIONE TRANSFERASE; LUCIFERASE; OSTEOCLAST DIFFERENTIATION FACTOR; RANTES; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; BONE MARROW; BOYDEN CHAMBER ASSAY; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE REPRESSION; GENE TARGETING; HEMATOPOIETIC STEM CELL; MACROPHAGE; MICROARRAY ANALYSIS; MONITORING; MONOCYTE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOCLAST; OSTEOCLASTOGENESIS; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RECEPTOR GENE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CYCLOSPORINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PERTUSSIS TOXIN; RECEPTORS, CHEMOKINE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 29644442713     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.051001     Document Type: Article

References (38)

1. Teitelbaum SL 2000 Bone resorption by osteoclasts. Science 289:1504-1508.
2. Chambers TJ 2000 Regulation of the differentiation and function of osteoclasts. J Pathol 192:4-13.
3. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T 2002 Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277:41147-41156.
4. Macián F, López-Rodríguez C, Rao A 2001 Partners in transcription: NFAT and AP-1, Oncogene 20:2476-2489.
5. Hogan PG, Chen L, Nardone J, Rao A 2003 Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17:2205-2232.
6. Hirotani H, Tuhoy NA, Woo JT, Stern PH, Clipstone NA 2003 The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 279:13984-13992.
7. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL 1991 Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-840.
8. 2+ signals and immunosuppression. Nature 383:837-840.
9. Loh C, Shaw KT, Carew J, Viola JP, Luo C, Perrino BA, Rao A 1996 Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 271:10884-10891.
10. Shibasaki F, Price ER, Milan D, McKeon F 1996 Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382:370-373.
11. Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M 2000 Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96:671-675.
12. Han JH, Choi SJ, Kurihara N, Koide M, Oba Y, Roodman GD 2001 Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor B ligand. Blood 97:3349-3353.
13. Fuller K, Owens JM, Chambers TJ 1995 Macrophage inflammatory protein-1α and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J Immunol 154:6065-6072.
14. Scheven BAA, Milne JS, Hunter I, Robins SP 1999 Macrophage-inflammatory protein-1α regulates preosteoclast differentiation in vitro. Biochem Biophys Res Commun 254:773-778.
15. Kukita T, Nomiyama H, Ohmoto Y, Kukita A, Shuto T, Hotokebuchi T, Sugioka Y, Miura R, Iijima T 1997 Macrophage inflammatory protein-1α (LD78) expressed in human bone marrow: Its role in regulation of hematopoiesis and osteoclast recruitment. Lab Invest 76:399-406.
16. Kukita T, Nakao J, Hamada F, Kukita A, Inai T, Kurisu K, Nomiyama H 1992 Recombinant LD78 protein, a member of the small cytokine family, enhances osteoclast differentiation in rat bone marrow culture system. Bone Miner 19:215-223.
17. Okamatsu Y, Kim D, Battaglino R, Sasaki H, Spate U, Stashenko P 2004 MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival. J Immunol 173:2084-2090.
18. Meiyanto E, Hoshijima M, Ogawa T, Ishida N, Takeya T 2001 Osteoclast differentiation factor modulates cell cycle machinery and causes a delay in S phase progression in RAW264 cells. Biochem Biophys Res Commun 282:278-283.
19. Sakai N, Ogawa T, Koga S, Samori H, Yogo K, Ishida N, Takeya T 2004 A novel assessment system for bisphosphonates using mouse RAW264 cells and biomimetic hydroxyapatite-coated plates. Preclinica 2:57-66.
20. Kumagai N, Ohno K, Tameshige R, Hoshijima M, Yogo K, Ishida N, Takeya T 2004 Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-B and important for progression to multinucleated cell formation. Biochem Biophys Res Commun 325:758-768.
21. Neal JW, Clipstone NA 2001 Glycogen Synthase Kinase-3 Inhibits the DNA Binding Activity of NFATc. J Biol Chem 276:3666-3673.
22. Mackay CR 2001 Chemokines: Immunology's high impact factors. Nat Immunol 2:95-107.
23. Aksamit RR, Falk W, Leonard EJ 1981 Chemotaxis by mouse macrophage cell lines. J Immunol 126:2194-2199.
24. Lean JM, Murphy C, Fuller K, Chambers TJ 2002 CCL9/MIP-1 gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J Cell Biochem 87:386-393.
25. Menten P, Wuyts A, Damme JV 2002 Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13:455-481.
26. Rollins BJ 1997 Chemokines. Blood 90:909-928.
27. Ko J, Kim IS, Jang SW, Lee YH, Shin SY, Min DS, Na DS 2002 Leukotactin-1/CCL15-induced chemotaxis signaling through CCR1 in HOS cells. FEBS Lett 515:159-164.
28. Nardelli B, Tiffany HL, Bong GW, Yourey PA, Morahan DK, Li Y, Murphy PM, Alderson RF 1999 Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1. J Immunol 162:435-444.
29. Watanabe T, Kukita T, Kukita A, Wada N, Toh K, Nagata K, Nomiyama H, Iijima T 2004 Direct stimulation of osteoclastogenesis by MIP-1α: Evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol 180:193-201.
30. Vignery A 2000 Osteoclasts and giant cells: Macrophage-macrophage fusion mechanism. J Exp Pathol 81:291-304.
31. Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H 2004 RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200:941-946.
32. +T cells. Science 270:1811-1815.
33. Doranz BJ, Rucker J, Yi Y, Smith RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW 1996 A dual-tropic primary HIV-1 isolate that use fusion and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
34. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA 1996 CC CKR5: A rantes, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
35. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J 1996 The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
36. Broxmeyer H, Cooper S, Hangoc G, Gao JL, Murphy PM 1999 Dominant myelopoietic effector functions mediated by chemokine receptor CCR1. J Exp Med 189:1987-1992.
37. Topham PS, Csizmadia V, Soler D, Mines D, Gerard CJ, Salant DJ, Hancock WW 1999 Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest 104:1549-1557.
38. Haringman JJ, Ludikhuize J, Tak PP 2004 Chemokines in joint disease; the key to inflammation? Ann Rheum Dis 63:1186-1194.